Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

KKR Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

KKR şirketinin toplam hissedar öz sermayesi $58.5B ve toplam borcu $50.2B olup, bu da borç-öz sermaye oranını 85.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $348.5B ve $289.9B dir.

Anahtar bilgiler

85.8%

Borç/özkaynak oranı

US$50.19b

Borç

Faiz karşılama oranı	n/a
Nakit	US$40.71b
Eşitlik	US$58.53b
Toplam yükümlülükler	US$289.94b
Toplam varlıklar	US$348.47b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: KKR 'nin kısa vadeli varlıkları ( $94.1B ) kısa vadeli yükümlülüklerini ( $53.0B ) aşıyor.

Uzun Vadeli Yükümlülükler: KKR 'un kısa vadeli varlıkları ( $94.1B ) uzun vadeli yükümlülüklerini ( $236.9B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: KKR 'nin net borç/öz sermaye oranı ( 16.2% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: KKR 'nin borç/öz sermaye oranı son 5 yılda 91.1% seviyesinden 85.8% seviyesine düştü.

Borç Kapsamı: KKR 'nin borcu işletme nakit akışı ( 15.9% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: KKR şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.

KKR Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

KKR Reportedly to Weigh Takeover Bid for ASMPT

Brookfield Reportedly Eyes Singapore Post

Thoma Bravo, L.P. completed the acquisition of Darktrace plc (LSE:DARK) from KKR Dark Aggregator, Summit partners.

Leonard Green & Partners, L.P. entered into an agreement to acquire GeoStabilization International LLC from KKR Americas Fund XII LP, a fund managed by KKR & Co. Inc. (NYSE:KKR).

Nomura Holdings and Mizuho Financial Group Reportedly Leading Bidders for Avendus Capital

Earnings Tell The Story For KKR & Co. Inc. (NYSE:KKR)

Impilo AB and KKR Health Care Strategic Growth Fund II SCSp managed by KKR & Co. Inc. (NYSE:KKR) completed the acquisition of an unknown minority stake in Immedica Pharma from Impilo AB.

Nomura Reportedly Enters the Race to Acquire Avendus

Alkem Reportedly Joins $3 Billion Race for JB Chem as Torrent Pauses Talks

Carlyle, Mizuho & Premji Invest Reportedly Aim for Avendus

KKR & Co. Inc. (NYSE:KKR) and Mirastar Real Estate Investment Management Limited acquired Portfolio of Five Prime Logistics assets from Peel Logistics Management Limited.

KKR's Trillion-Dollar Playbook: How Shareholders Could Win Big

KKR & Co. Inc. (NYSE:KKR) acquired Kent Valley industrial building in Auburn from Blackstone Real Estate Advisors L.P for $58.4 million.

KKR Reportedly in Talks to Buy The Parking Spot in $1.4 Billion Deal

KKR, TPG Capital, Apax Partners and Other PE Firms Reportedly Eye Purchase of Sahajanand Medical Technologies

EQT Private Capital Asia agreed to acquire PropertyGuru Group Limited (NYSE:PGRU) from TPG Capital, L.P., KKR & Co. Inc. (NYSE:KKR), REA Group Limited (ASX:REA) and others for $1 billion.

KKR-Led Consortium Reportedly Starts Sale Process for Around $3.0 Billion Philippines Hospital Business

Inter Infrastructure Capital a fund managed by IKANO Fund Management SA acquired 12.25% stake in Q-Park N.V. from company's existing shareholders and KKR Global Infrastructure Investors II LP a fund managed by KKR & Co. Inc. (NYSE:KKR).

Torrent Pharma Reportedly is Said to Seek Raising $3 Billion for KKR's Stake in JB Chemicals

KKR European Fund VI, a fund managed by KKR & Co. Inc. (NYSE:KKR) entered into an agreement to an additional 50% stake in FGS Global Inc from WPP plc (LSE:WPP) for approximately $780 million.

KKR European Fund VI, a fund managed by KKR & Co. Inc. (NYSE:KKR) entered into an agreement to an additional 50% stake in FGS Global Inc from WPP plc (LSE:WPP) for approximately $780 million.

Second quarter dividend of US$0.17 announced

Price target increased by 8.6% to US$132

Second quarter 2024 earnings released: EPS: US$0.75 (vs US$0.98 in 2Q 2023)

Now 22% overvalued after recent price rise

KKR & Co. Inc. Declares Dividend for the Second Quarter of 2024, Payable on August 27, 2024

Torrent Pharmaceuticals Reportedly in Talks to Acquire KKR’s Stake in JB Chemicals

General Atlantic, Other PE Funds Reportedly in Talks for Majority Stake in AIMS

KKR North America Fund XIII SCSp managed by KKR & Co. Inc. (NYSE:KKR) and Dragoneer Investment Group, LLC entered into a definitive agreement to acquire Instructure Holdings, Inc. from Thoma Bravo, L.P. and others for $3.6 billion.

A joint venture between T-Mobile US, Inc. (NasdaqGS:TMUS) and KKR & Co. Inc. (NYSE:KKR) entered into a definitive agreement to acquire MetroNet Holdings, LLC from Oak Hill Capital Management, LLC and the Cinelli family.

KKR & Co. Inc. (NYSE:KKR) along with Tower Bridge Infrastructure Partners LP managed by Global Infrastructure Management, LLC completed the acquisition of 40.86222% stake in Vantage Towers AG (DB:VTWR) from Vodafone GmbH.

KKR & Co. Inc. (NYSE:KKR) along with Tower Bridge Infrastructure Partners LP managed by Global Infrastructure Management, LLC completed the acquisition of 40.86222% stake in Vantage Towers AG (DB:VTWR) from Vodafone GmbH.

KKR Reportedly Mulls Options for Stake in Biotage

KKR Reportedly Considers $3 Billion Sale of KITO Crosby

KKR & Co. Inc. to Report Q2, 2024 Results on Jul 31, 2024

KKR Reportedly Considers Reviving Multibillion-Dollar Sale of Goodpack

Francisco, KKR Reportedly to Consider Takeover of Instructure

KKR Asian Fund IV and KKR & Co. Inc. (NYSE:KKR) agreed to acquire unknown controlling stake in Baby Memorial Hospital Limited.

KKR: Asset Growth Justifies Its Strong Rally

Carlyle, KKR Reportedly Shortlisted to Bid for Discover's US Student Loan Portfolio

Renesas Electronics Corporation (TSE:6723) completed the acquisition of acquire Transphorm, Inc. (NasdaqCM:TGAN) from KKR & Co. Inc. (NYSE:KKR), KKR Phorm Investors L.P., KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc. and KKR Phorm Investors GP LLC.

KKR: Overvalued Due To Rapid Multiple Expansion Despite S&P 500 Entrance

KKR Reportedly Taps Morgan Stanley for Loscam Play

Ten Suitors Reportedly in Race for Loscam

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin